» Authors » Xinchun Zhao

Xinchun Zhao

Explore the profile of Xinchun Zhao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 31
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Zhou X, Xu W, Cai Y, Mu C, Zhao X, et al.
Cancer Metab . 2024 Feb; 12(1):6. PMID: 38365771
Background: Metastasis is the leading cause of death among prostate cancer (PCa) patients. Obesity is associated with both PCa-specific and all-cause mortality. High-fat diet (HFD) is a risk factor contributing...
2.
Li D, Zhou X, Xu W, Chen Y, Mu C, Zhao X, et al.
Cancer Med . 2023 Jul; 12(15):16405-16415. PMID: 37501397
Background: Metastatic castration-resistant prostate cancer (mCRPC) remains fatal and incurable, despite a variety of treatments that can delay disease progression and prolong life. Immune checkpoint therapy is a promising treatment....
3.
Zhao X, Jiang Y, Xu M, Hu J, Feng N, Deng H, et al.
Toxicol Appl Pharmacol . 2022 Feb; 440:115921. PMID: 35157906
Breast cancer is the primary cause of cancer-related deaths in women. Tamoxifen (TAM) is the preferred drug for treating premenopausal luminal-type breast cancer, but TAM resistance restricts its ability to...
4.
Zhao X, Yongchun Z, Qian H, Sanhui G, Jie L, Hong Y, et al.
Cancer Biol Med . 2020 Apr; 17(1):76-87. PMID: 32296577
Oncogenes have been shown to be drivers of non-small cell lung cancer (NSCLC), yet the tumor suppressing genes involved in lung carcinogenesis remain to be systematically investigated. This study aimed...
5.
Zhang Y, Zhao X, Zhou Y, Wang M, Zhou G
Front Med . 2019 Oct; 14(3):318-326. PMID: 31571161
In order to unveil ubiquitin pathway genes (UPGs) that are essential for non-small cell lung cancer (NSCLC) cell proliferation, we recently conducted a siRNA screening experiment to knockdown the expression...
6.
Zhou G, Zhao X
Front Med . 2017 Dec; 12(2):236-238. PMID: 29209916
Recently, Ng et al. reported that the A:T > T:A substitutions, proposed to be a signature of aristolochic acid (AA) exposure, were detected in 76/98 (78%) of patients with hepatocellular...